Annual Operating Expenses
$27.84 M
-$16.50 M-37.21%
31 December 2023
Summary:
NRx Pharmaceuticals annual total operating expenses is currently $27.84 million, with the most recent change of -$16.50 million (-37.21%) on 31 December 2023. During the last 3 years, it has fallen by -$23.55 million (-45.83%). NRXPW annual operating expenses is now -75.96% below its all-time high of $115.80 million, reached on 31 December 2021.NRXPW Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.02 M
-$4.03 M-57.13%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly total operating expenses is currently $3.02 million, with the most recent change of -$4.03 million (-57.13%) on 30 September 2024. Over the past year, it has dropped by -$2.79 million (-47.97%). NRXPW quarterly operating expenses is now -84.96% below its all-time high of $20.10 million, reached on 30 September 2021.NRXPW Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.2% | -48.0% |
| 3 y3 years | -45.8% | -85.0% |
| 5 y5 years | - | +1548.6% |
NRXPW Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.0% | at low | -85.0% | +100.0% |
| 5 y | 5 years | -76.0% | +3803.2% | -85.0% | +100.0% |
| alltime | all time | -76.0% | +3803.2% | -85.0% | +100.0% |
NRx Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.02 M(-57.1%) |
| June 2024 | - | $7.05 M(+17.5%) |
| Mar 2024 | - | $6.00 M(+36.1%) |
| Dec 2023 | $27.84 M(-37.2%) | $4.41 M(-24.1%) |
| Sept 2023 | - | $5.81 M(-39.5%) |
| Dec 2022 | $44.34 M(-61.7%) | - |
| June 2022 | - | $9.60 M(-38.9%) |
| Mar 2022 | - | $15.71 M(-100.1%) |
| Dec 2021 | $115.80 M | -$20.00 B(<-9900.0%) |
| Sept 2021 | - | $20.10 M(+17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $17.12 M(+303.8%) |
| Mar 2021 | - | $4.24 M(>+9900.0%) |
| Dec 2020 | $51.39 M(+7105.3%) | $0.00(-100.0%) |
| Sept 2020 | - | $5.15 M(-5012.5%) |
| June 2020 | - | -$104.82 K(-187.9%) |
| Mar 2020 | - | $119.30 K(-37.5%) |
| Dec 2019 | $713.19 K | $190.96 K(+4.2%) |
| Sept 2019 | - | $183.31 K(+4.3%) |
| June 2019 | - | $175.74 K(+7.7%) |
| Mar 2019 | - | $163.18 K |
FAQ
- What is NRx Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual operating expenses year-on-year change?
- What is NRx Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly operating expenses year-on-year change?
What is NRx Pharmaceuticals annual total operating expenses?
The current annual operating expenses of NRXPW is $27.84 M
What is the all time high annual operating expenses for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total operating expenses is $115.80 M
What is NRx Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, NRXPW annual total operating expenses has changed by -$16.50 M (-37.21%)
What is NRx Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of NRXPW is $3.02 M
What is the all time high quarterly operating expenses for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total operating expenses is $20.10 M
What is NRx Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, NRXPW quarterly total operating expenses has changed by -$2.79 M (-47.97%)